Newsfeeds - Spark Newswire

4 minute read

Aytu BioPharma Announces Continuing Availability Of ADHD Medication Adzenys XR-ODT(R) In Response To Reported Generic Adderall(R) XR Supply Disruptions

Today, 6:52 AM

Aytu BioPharma, Inc. (the Company or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on developing and commercializing novel therapeutics, with a development pipeline addressing rare, pediatric-onset

AYTU

2 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s After-Market Session

By Benzinga Insights

Today, 6:52 AM

Gainers Benitec Biopharma (NASDAQ:BNTC) shares increased by 9.8% to $0.35 during Tuesday's after-market session. The company's market cap stands at $9.0 million.

ANPC

1 minute read

Earnings

Earnings Scheduled For September 27, 2022

By Benzinga Insights

Today, 6:52 AM

Companies Reporting Before The Bell • Ferguson (NYSE:FERG) is projected to report quarterly earnings at $2.79 per share on revenue of $7.86 billion.

AYTU

1 minute read

Earnings

Aytu BioPharma’s Earnings: A Preview

By Benzinga Insights

Today, 6:52 AM

Aytu BioPharma (NASDAQ:AYTU) is set to give its latest quarterly earnings report on Tuesday, 2022-09-27. Here's what investors need to know before the announcement. Analysts estimate that Aytu BioPharma will report an earnings per share (EPS) of $-0.37.

AYTU

24 minute read

Options

Stocks That Hit 52-Week Lows On Monday

By Benzinga Insights

Today, 6:52 AM

On Monday, 429 stocks made new 52-week lows.

ADCT

1 minute read

Aytu BioPharma Announces Addition Of Fourth Patent License For AR101/Enzastaurin

By Bill Haddad

Today, 6:52 AM

ENGLEWOOD, CO / ACCESSWIRE / September 14, 2022 / Aytu BioPharma, Inc. (the Company or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on developing and commercializing novel therapeutics, with a

AYTU